Department of Women's and Children's Health, Uppsala University Hospital, Uppsala University, 751 85, Uppsala, Sweden.
Emotion Neuroimaging (EGG) Lab, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
BMC Womens Health. 2022 Feb 11;22(1):35. doi: 10.1186/s12905-022-01612-5.
Although previous studies report an association between Premenstrual Dysphoric Disorder (PMDD) and suicidal ideation, most studies have only established a provisional and retrospective diagnosis of PMDD fundamentally invalidating the diagnosis. Therefore, the aim of this study was to describe the prevalence and to explore correlates of current suicidal ideation in the late luteal phase in women with prospectively assessed and confirmed PMDD.
Participants were 110 women who attended the pre-randomization baseline visit of two randomized placebo-controlled clinical trials between January 15, 2017 and October 19, 2019. PMDD was diagnosed prospectively in line with DSM-5 criteria. Current suicidal ideation was measured by the MADRS-S in the late luteal phase. Descriptive statistics were presented and logistic regression analyses were carried out to explore the association between psychosocial and health characteristics and current suicidal ideation, presenting unadjusted odds ratios (OR) and 95% confidence intervals (CI).
Current suicidal ideation was reported by nearly 40% of women with confirmed PMDD (n = 43, 39.1%). Previous psychological treatment for PMDD and higher depressive symptoms in the late luteal phase were positively associated with current suicidal ideation (OR 5.63, 95% CI 1.07-29.49, and OR 1.17, 95% CI 1.10-1.25, respectively), whereas higher ratings of self-rated health were associated with lower odds ratios for current suicidal ideation (OR 0.98, 95% CI 0.96-0.99).
A substantial proportion of women with confirmed PMDD report current suicidal ideation in the late luteal phase. Results point to a need for better awareness and screening of suicidal ideation in women with PMDD.
尽管先前的研究报告称经前烦躁障碍(PMDD)与自杀意念有关,但大多数研究仅对 PMDD 进行了临时性和回顾性诊断,这从根本上使 PMDD 的诊断无效。因此,本研究旨在描述前瞻性评估和确认的 PMDD 患者黄体晚期当前自杀意念的发生率,并探讨其相关因素。
参与者为 110 名女性,她们于 2017 年 1 月 15 日至 2019 年 10 月 19 日参加了两项随机安慰剂对照临床试验的预随机基线访视。PMDD 是根据 DSM-5 标准进行前瞻性诊断的。在黄体晚期使用 MADRS-S 量表测量当前的自杀意念。呈现了描述性统计数据,并进行了逻辑回归分析,以探讨社会心理和健康特征与当前自杀意念之间的关联,呈现未经调整的优势比(OR)和 95%置信区间(CI)。
近 40%的确诊 PMDD 女性报告了当前的自杀意念(n=43,39.1%)。PMDD 之前的心理治疗和黄体晚期更高的抑郁症状与当前的自杀意念呈正相关(OR 5.63,95%CI 1.07-29.49,和 OR 1.17,95%CI 1.10-1.25),而自我评定健康状况的评分较高与当前自杀意念的可能性较低呈负相关(OR 0.98,95%CI 0.96-0.99)。
相当一部分确诊 PMDD 的女性在黄体晚期报告了当前的自杀意念。研究结果表明,PMDD 患者需要更好地意识到和筛查自杀意念。